当前位置:首页 - 行情中心 - 鹭燕医药(002788) - 财务分析 - 现金流量表

鹭燕医药

(002788)

  

流通市值:42.39亿  总市值:43.13亿
流通股本:3.82亿   总股本:3.89亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,953,687,628.335,816,870,707.9322,904,511,831.116,996,652,201.78
  收到的税费返还603,751.23462,605.722,6001,464,967.68
  收到其他与经营活动有关的现金134,134,533.2109,467,188.1580,549,063.44190,603,420.38
  经营活动现金流入小计12,088,425,912.765,926,800,501.822,985,063,494.5417,188,720,589.84
  购买商品、接受劳务支付的现金11,396,163,856.655,839,584,827.5621,015,638,295.315,886,079,983.03
  支付给职工以及为职工支付的现金307,914,887.39168,595,625.15588,068,454.83438,936,783.94
  支付的各项税费190,315,886.1399,994,050.29397,362,442.77301,526,275.51
  支付其他与经营活动有关的现金295,140,316.568,593,561.31295,594,163.12232,474,668.61
  经营活动现金流出小计12,189,534,946.676,176,768,064.3122,296,663,356.0216,859,017,711.09
  经营活动产生的现金流量净额-101,109,033.91-249,967,562.51688,400,138.52329,702,878.75
二、投资活动产生的现金流量:
  收回投资收到的现金1,359,367.75---
  处置固定资产、无形资产和其他长期资产收回的现金净额110,055.7222,459.2834,220.96832,458.48
  处置子公司及其他营业单位收到的现金净额1,921,818.99---
  投资活动现金流入小计3,391,242.4622,459.2834,220.96832,458.48
  购建固定资产、无形资产和其他长期资产支付的现金79,254,596.2442,260,792.18233,736,964.18185,657,832.08
  投资支付的现金-010,092,5008,092,500
  支付其他与投资活动有关的现金--580,071.56580,071.56
  投资活动现金流出小计79,254,596.2442,260,792.18244,409,535.74194,330,403.64
  投资活动产生的现金流量净额-75,863,353.78-42,238,332.98-243,575,314.78-193,497,945.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0618,000618,000
  其中:子公司吸收少数股东投资收到的现金-0618,000618,000
  取得借款收到的现金5,386,999,574.853,040,170,843.19,500,495,716.137,320,034,703.46
  收到其他与筹资活动有关的现金-0--
  筹资活动现金流入小计5,386,999,574.853,040,170,843.19,501,113,716.137,320,652,703.46
  偿还债务支付的现金4,996,288,720.672,705,103,287.269,549,761,270.577,249,516,252.13
  分配股利、利润或偿付利息支付的现金80,160,233.7343,614,845.03314,126,444.16264,366,607.59
  其中:子公司支付给少数股东的股利、利润374,643.53-166,994.96-
  支付其他与筹资活动有关的现金28,681,770.1613,341,413.2177,309,465.3249,443,092.09
  筹资活动现金流出小计5,105,130,724.562,762,059,545.59,941,197,180.057,563,325,951.81
  筹资活动产生的现金流量净额281,868,850.29278,111,297.6-440,083,463.92-242,673,248.35
四、汇率变动对现金及现金等价物的影响-393,081.99-227,983.98-465,899.86-396,890.77
五、现金及现金等价物净增加额104,503,380.61-14,322,581.874,275,459.96-106,865,205.53
  加:期初现金及现金等价物余额345,200,364.2345,200,364.2340,924,904.24340,924,904.24
  期末现金及现金等价物余额449,703,744.81330,877,782.33345,200,364.2234,059,698.71
补充资料:
  净利润139,814,750.35-278,981,375.38-
  资产减值准备-1,234,804.4-20,211,650.57-
  固定资产和投资性房地产折旧39,721,708.88-69,249,649.37-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧39,721,708.88---
  无形资产摊销3,220,414.37-5,234,678.7-
  长期待摊费用摊销5,237,913.51-11,129,136.78-
  处置固定资产、无形资产和其他长期资产的损失481,570.17--264,930.44-
  固定资产报废损失118,533.08-435,541.72-
  公允价值变动损失0---
  财务费用80,625,358.95-178,306,026.62-
  投资损失11,590,942.18-14,334,376.29-
  递延所得税-2,222,897.95--2,935,608.35-
  其中:递延所得税资产减少-2,088,845.83--2,667,504.12-
    递延所得税负债增加-134,052.12--268,104.23-
  存货的减少105,150,507.7--176,355,961.4-
  经营性应收项目的减少191,862,467.8--444,365,687.72-
  经营性应付项目的增加-704,324,004.64-672,289,020.62-
  现金的期末余额449,703,744.81-345,200,364.2-
  减:现金的期初余额345,200,364.2-340,924,904.24-
  现金及现金等价物的净增加额104,503,380.61-4,275,459.96-
公告日期2026-08-182026-04-212026-04-212025-10-27
审计意见(境内)标准无保留意见
TOP↑